EP2306839A4 - Gacyclidine formulations - Google Patents

Gacyclidine formulations

Info

Publication number
EP2306839A4
EP2306839A4 EP09767730A EP09767730A EP2306839A4 EP 2306839 A4 EP2306839 A4 EP 2306839A4 EP 09767730 A EP09767730 A EP 09767730A EP 09767730 A EP09767730 A EP 09767730A EP 2306839 A4 EP2306839 A4 EP 2306839A4
Authority
EP
European Patent Office
Prior art keywords
gacyclidine
formulations
gacyclidine formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09767730A
Other languages
German (de)
French (fr)
Other versions
EP2306839A1 (en
Inventor
Thomas Jay Lobl
John Vinton Schloss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurosystec Corp
Original Assignee
Neurosystec Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosystec Corp filed Critical Neurosystec Corp
Publication of EP2306839A1 publication Critical patent/EP2306839A1/en
Publication of EP2306839A4 publication Critical patent/EP2306839A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0097—Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP09767730A 2008-06-19 2009-06-18 Gacyclidine formulations Withdrawn EP2306839A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7413408P 2008-06-19 2008-06-19
PCT/US2009/047801 WO2009155421A1 (en) 2008-06-19 2009-06-18 Gacyclidine formulations

Publications (2)

Publication Number Publication Date
EP2306839A1 EP2306839A1 (en) 2011-04-13
EP2306839A4 true EP2306839A4 (en) 2011-08-17

Family

ID=41434441

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09767730A Withdrawn EP2306839A4 (en) 2008-06-19 2009-06-18 Gacyclidine formulations

Country Status (2)

Country Link
EP (1) EP2306839A4 (en)
WO (1) WO2009155421A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116267896B (en) * 2023-03-13 2024-03-08 重庆师范大学 Application of squalene in improving survival rate of bee sperms and semen preservation method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1861104A4 (en) * 2005-03-04 2011-12-14 Neurosystec Corp Improved gacyclidine formulations
GB0601179D0 (en) * 2006-01-20 2006-03-01 Univ Cambridge Tech Therapies for psychotic disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHUNG H ET AL: "Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 71, no. 3, 28 April 2001 (2001-04-28), pages 339 - 350, XP004234531, ISSN: 0168-3659, DOI: 10.1016/S0168-3659(00)00363-1 *
See also references of WO2009155421A1 *

Also Published As

Publication number Publication date
WO2009155421A1 (en) 2009-12-23
EP2306839A1 (en) 2011-04-13

Similar Documents

Publication Publication Date Title
GB0815435D0 (en) Formulations
ZA201106050B (en) Dye-polymers formulations
GB2459691B (en) Formulations
GB0823269D0 (en) Formulations
ZA201006315B (en) Fulvestrant formulations
IL269369A (en) Improved formulations
GB0821789D0 (en) Formulations
GB0919210D0 (en) Formulations
EP2307021A4 (en) Formulations
GB0806978D0 (en) Novel formulations
GB0822633D0 (en) Formulation
IL213559A0 (en) Oral formulations
ZA201004772B (en) Novel formulation
GB0814376D0 (en) Formulation
EP2306839A4 (en) Gacyclidine formulations
GB0705179D0 (en) Formulations
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
IL217390A0 (en) Formulations
GB0816876D0 (en) Formulations
GB0823486D0 (en) Formulations
GB0823493D0 (en) Formulations
GB0817079D0 (en) Formulations
GB0807906D0 (en) Formulations

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110117

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

A4 Supplementary search report drawn up and despatched

Effective date: 20110714

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/00 20060101ALI20110708BHEP

Ipc: A61K 9/107 20060101ALI20110708BHEP

Ipc: A61K 9/51 20060101ALI20110708BHEP

Ipc: A61K 9/00 20060101ALI20110708BHEP

Ipc: A61K 31/451 20060101ALI20110708BHEP

Ipc: A61K 31/445 20060101ALI20110708BHEP

Ipc: A61K 31/135 20060101ALI20110708BHEP

Ipc: A61K 31/13 20060101ALI20110708BHEP

Ipc: A61K 31/453 20060101AFI20110708BHEP

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120214